IBRXImmunityBio, Inc.
Is it safe?
Serious red flags: a balance sheet under strain, accounting red flags, and heavy debt (CCC). Everything else is secondary until this clears.
Elevated financial-distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Several accounting flags in the manipulation-likely range Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).
Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.
Insiders were net sellers (-$1.1M, 90 days to Oct 8, 2026), selling is often routine.
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -97% · now 9% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can IBRX take a bad year?
The deepest fall in IBRX's price history on file is −97%; it is 9.0% below its high today.
Altman Z-score · distress below 1.8 · safe above 3 · distress zone, the model puts this in the bankruptcy range
- Cash runway
- 1.3 years
Cash runway · burning $72M a quarter at the current rate
- Annualised volatility
- 102%
Annualised volatility · three times the market's own swing
- Worst drawdown on file
- −97%
Worst drawdown on file · −9.0% today
Details›
- Cash and short-term investments
- $357M
- EBITDA, trailing twelve months
- −$236M
- Operating profit, trailing twelve months
- −$252M
- Annualised volatilitytwo years of daily moves
- 102%
- Worst drawdown on file
- −97%
- Below its 52-week high
- 9.0%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.